🔎 Trials Near Me

Home › Steatotic Liver Disease › Illinois › Chicago

Steatotic Liver Disease clinical trials in Chicago, IL

6 studies for Steatotic Liver Disease are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

RecruitingPhase 3
  • 89bio Clinical Study Site, Chicago
Ages 18 to 75 · All sexes · Updated Oct 5, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

RecruitingPhase 3
  • 89bio Clinical Study Site, Chicago
Ages 18 to 80 · All sexes · Updated Oct 5, 2026 · NCT06318169

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

RecruitingPhase 3
  • University of Chicago Medical Center, Chicago
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

RecruitingPhase 3
  • Akero Clinical Study Site, Chicago
Ages 18 to 80 · All sexes · Updated Sep 21, 2026 · NCT06528314

Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

Recruiting
  • RUSH University Medical Center, Chicago
Ages 18 to 75 · All sexes · Updated May 19, 2026 · NCT04054310

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

RecruitingPhase 2
  • Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Ages 16 to 20 · All sexes · Updated Jan 21, 2026 · NCT06355310

About Steatotic Liver Disease

Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.

More about Steatotic Liver Disease on MedlinePlus

Steatotic Liver Disease trials in other cities

Other studies in Chicago

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.